Form 4: HealthEquity Director Boosts Stake with Restricted Stock Unit Acquisition

HealthEquity, Inc. Director Gayle Furgurson Wellborn acquired 2,003 shares of common stock through restricted stock units, increasing her direct beneficial ownership to 19,733 shares.

Summary

• HealthEquity, Inc. Director Gayle Furgurson Wellborn acquired 2,003 shares of common stock on June 26, 2025.
• These shares were acquired as Restricted Stock Units (RSUs) at a price of $0 per unit, indicating a grant.
• Each RSU represents a contingent right to receive one share of the issuer's common stock.
• The RSUs are set to vest in full on the date of HealthEquity's next annual stockholder meeting, at which point vested shares will be delivered.
• Following this transaction, Ms. Wellborn's direct beneficial ownership of HealthEquity common stock increased to 19,733 shares.
• Ms. Wellborn also holds stock options to buy 2,439 shares at an exercise price of $47.21, expiring on August 1, 2027, and 4,339 shares at an exercise price of $50.41, expiring on February 1, 2028, both of which are immediately exercisable.

Sentiment

Score: 7

Explanation: The acquisition of additional equity by a director, particularly through a grant of Restricted Stock Units, is generally a positive indicator of insider confidence in the company's future performance and aligns their interests with shareholders. No negative transactions were reported.

Positives

• An insider, a Director, acquired additional equity in the company, which typically signals confidence in the company's future performance.
• The acquisition of 2,003 Restricted Stock Units (RSUs) at a price of $0 indicates compensation or a grant, aligning the director's interests with shareholders.

Future Outlook

The acquired Restricted Stock Units are scheduled to vest in full on the date of HealthEquity's next annual stockholder meeting, at which point the shares will be delivered to the reporting person.

Management Comments

• The Power of Attorney given by Ms. Wellborn was previously filed with the U.S. Securities and Exchange Commission on June 26, 2023, as an exhibit to a statement on Form 4 filed by Ms. Wellborn with respect to HealthEquity, Inc. and is hereby incorporated by reference.

Industry Context

This Form 4 filing reflects an individual insider transaction, which is a routine disclosure for publicly traded companies. It does not provide broader industry trends or competitive analysis but indicates ongoing equity compensation practices for board members within the financial services or healthcare technology sector, where HealthEquity operates.

Comparison to Industry Standards

• This Form 4 filing is a standard regulatory disclosure for insider transactions and does not contain information for direct comparison to specific industry benchmarks, comparable companies, or project results. Insider equity grants are common practice across industries for aligning management and director interests with shareholders.

Related Party Transactions

• The acquisition of 2,003 Restricted Stock Units by Director Gayle Furgurson Wellborn is a related party transaction, as it involves an insider receiving equity compensation from the company.

Stakeholder Impact

• Shareholders: The acquisition of additional equity by a director can be perceived positively, signaling management's confidence and aligning their interests with shareholder value.
• Employees: No direct impact on employees is indicated by this filing.
• Customers: No direct impact on customers is indicated by this filing.
• Suppliers: No direct impact on suppliers is indicated by this filing.
• Creditors: No direct impact on creditors is indicated by this filing.

Next Steps

• The 2,003 Restricted Stock Units are expected to vest in full on the date of HealthEquity's next annual stockholder meeting.
• Vested shares will be delivered to Gayle Furgurson Wellborn upon vesting.

Key Dates

Recommendation

Keywords

HealthEquity, HQY, SEC Form 4, Insider Transaction, Restricted Stock Units, RSU, Stock Options, Director, Beneficial Ownership, Equity Compensation